INNOCARE

09969
10.0604.46% ( -0.470 )
Delay Closed: Nov 20, 16:08:14

Valuation

Current ValuationThe current P/E ratio is 11.72, within the reasonable range, cheaper than 21.81% of the time in the past 3 years, and the industry ranks 10/78, the industry Median -4.64.

11.72xP/E
Stock priceHK$10.53Earnings per shareHK$0.90

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0145290435580

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09995HKREMEGEN
4.49x512.28%HK$34.15B
01530HK3SBIO
3.48x71.09%HK$33.16B
09969HKINNOCARE
11.72x13.45%HK$18.61B
02142HKHBM HOLDINGS-B
12.94x8.46%HK$8.57B
01167HKJACOBIO-B
5.48x--HK$3.24B
02509HKQYUNS-B
4.96x23.95%HK$3.12B
06998HKEDDING GENOR
12.31x--HK$3.10B
02197HKCLOVER BIO-B
1.99x--HK$1.95B
01061HKESSEX BIO-TECH
4.03x1.60%HK$1.07B
02566HKJIUYUAN GENE
6.02x--HK$966.88M
00690HKUNI-BIO GROUP
7.63x--HK$370.22M
08158HKCRMI
2.59x--HK$71.20M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.